Biomedical subjects

L H Sanín

Publications and source records attributed to L H Sanín.

4 recordsLinked to original sources

PubMed2001

Effect of maternal lead burden on infant weight and weight gain at one month of age among breastfed infants.

INTRODUCTION: Transfer of lead from bone to the bloodstream increases during lactation. However, the effect of maternal lead burden on growth in breastfed newborns is still unknown. This study examined early postnatal growth in a cohort of healthy breastfed newborns in relation to maternal bone lead burden. METHODS: Lead levels were measured among 329 mother-infant pairs in umbilical cord blood at birth and in maternal and infant venous blood at 1 month postpartum. Maternal evaluations at 1 month postpartum included lead measures in blood and bone (measured in the tibia and the patella). Blood lead was determined by graphite furnace atomic absorption spectrophotometry. Bone lead was measured by (109)Cd Kx-radiograph fluorescence instrument. The primary endpoints were attained weight 1 month of age, and weight gain from birth to 1 month of age, which were analyzed in relation to lead biomarkers and relevant covariates by linear regression models. RESULTS: Infants studied had an average weight gain of 33.1 g/day (standard deviation [SD] = 11.6). Mean infant (at 1 month of age) and maternal blood lead levels were 5.6 microg/dL (SD = 3.0) and 9.7 microg/dL (SD = 4.1), respectively. Mean maternal bone lead levels were 10.1 microg of lead/g (SD = 10.3) and 15.29 microg of lead/g (SD = 15.2) of bone mineral for tibia and patella, respectively. Infant blood lead levels were inversely associated with weight gain, with an estimated decline of 15.1 g per microg/dL of blood lead. Children who were exclusively breastfed had significantly higher weight gains; however, this gain decreased significantly with increasing levels of patella lead. The multivariate regression analysis predicted a 3.6-g decrease in weight at 1 month of age per microg of lead per gram bone mineral increase in maternal patella lead levels. CONCLUSIONS: Maternal lead burden is negatively associated to infant attained weight at 1 month of age and to postnatal weight gain from birth to 1 month of age. Additional studies are needed to better understand this source of exposure and to develop interventions to minimize its impact.

Adult↗

PubMed1997

Decrease in birth weight in relation to maternal bone-lead burden.

OBJECTIVES: Birth weight predicts infant survival, growth, and development. Previous research suggests that low levels of fetal lead exposure, as estimated by umbilical cord blood-lead levels at birth, may have an adverse effect on birth weight. This report examines the relationship of lead levels in cord blood and maternal bone to birth weight. METHODS: Umbilical cord and maternal venous blood samples and anthropometric and sociodemographic data were obtained at delivery and 1-month postpartum. Blood-lead levels were analyzed by atomic absorption spectrophotometry. Maternal tibia and patella lead levels were determined at 1-month postpartum with use of a spot-source 109Cd K-X-ray fluorescence instrument. The relationship between birth weight and lead burden was evaluated by multiple regression with control of known determinants of size at birth. RESULTS: Data on all variables of interest were obtained for 272 mother-infant pairs. After adjustment for other determinants of birth weight, tibia lead was the only lead biomarker clearly related to birth weight. The decline in birth weight associated to increments in tibia lead was nonlinear and accelerated at the highest tibia lead quartile. In the upper quartile, neonates were on average, 156 grams lighter than those in the lowest quartile. Other significant birth weight predictors included maternal nutritional status, parity, education, gestational age, and smoking during pregnancy. CONCLUSIONS: Our results indicate that bone-lead burden is inversely related to birth weight. Taken together with other research indicating that lead can mobilize from bone into plasma without detectable changes in whole blood lead, these findings suggest that bone lead might be a better biomarker than blood lead. Because lead remains in bone for years to decades, mobilization of bone lead during pregnancy may pose a significant fetal exposure with health consequences, long after maternal external lead exposure has declined.

Birth Weight↗

PubMedDate not supplied

[Length and weight at birth: the role of maternal nutrition].

OBJECTIVE: To identify determinants of weight (BW) and length at birth (BL). MATERIAL AND METHODS: We studied 481 mother-newborn pairs in three Mexico City hospitals. Multiple regression models were developed to identify statistically significant predictors of BW and BL with respect to a predetermined biological model. Independent variables included were: maternal anthropometry, age, smoking habits, and civil status, parental education, obstetric history, hypertension, and neonatal characteristics. RESULTS: In the group with calf circumference (CC), height and head circumference below the median BW was 133, 92 and 96 g lower (+/- 35 standard error -SE-, p < 0.01) than the group above the median, adjusting for socioeconomic, obstetric history, and neonatal characteristics (NC). In the group below the median CC or height, BL was 5.8 or 6.2 mm (+/- 1.9 mm SE, p < 0.01) respectively, adjusting for obstetric history and NC. CONCLUSIONS: Results suggest that maternal anthropometry is the most important predictor of birth size and that predictors for BW and BL differ.

Adult↗

PubMedDate not supplied

[Accumulation of lead in bone and its effects on health].

The adverse effects of lead have been known for long since the metal affects practically all organs and systems of the human body. Recently, toxic effects have been reported in the cardiovascular and nervous systems at lead levels previously considered to be secure. The main lead storage site in the body is bone. The toxicologic significance of this fact has been clarified only recently. The present study analyzes the role of lead as an endogenous source of exposure, as a chronic exposure biomarker and as a target organ. Recent advances to measure bone lead through fluorescent X-Rays are discussed. Additionally, the importance of bone lead from a public health perspective in places with a chronic history of exposure such as Mexico City, and in some occupational environments is reviewed with particular attention placed on reproductive age women, who are potential lead sources for the fetus and lactating infant.

Adult↗